Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Discussion

16 April 2021 (15:53 - 15:59)

Organised by:

7 More presentations in this session

Presentation thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction

Mr G. Neif Vieira Musse (Sao Paulo, BR)

Presentation thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - Commentary

Professor M. Minicucci (Botucatu, BR)

Presentation thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - discussion

Presentation thumbnail

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

Doctor C. Ballantyne (Houston, US)

Presentation thumbnail

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Commentary.

Professor U. Landmesser (Berlin, DE)

Access the full session

Session thumbnail

Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC)

The Event

ESC Preventive Cardiology 2021

16 April 2021 15:53 CET

You may be interested in

ESC TV Today

Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty

Webinar

Risk assessment and lipid management in primary prevention

Congress Session

The strength of scientific integration

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources